Log in

Relevant bibliographies by topics / Generic Drugs Market / Books

To see the other types of publications on this topic, follow the link: Generic Drugs Market.

Books on the topic 'Generic Drugs Market'

Author: Grafiati

Published: 5 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Generic Drugs Market.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

(Firm), Find/SVP. The market for generic drugs. FIND/SVP Research Publications Group, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Frost & Sullivan., ed. The U.S. market for generic drugs. Frost & Sullivan, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

inc, International Resource Development, ed. Generic drugs in the 1990s. International Resource Development, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Bassett, Pamela. Generic drugs: Technologies, trends, and market opportunities. D&MD, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Crandall, Mary Anne. The market for generic biologics. Edited by Heffner Steven and Kalorama Information LLC. Kalorama Information, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Gray, Lynn. The U.S. generic prescription drug industry. Business Communications Co., 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Gray, Lynn. The worldwide generic prescription drug industry. Business Communications Co., 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Handa, Pavan. The worldwide generic prescription drug industry. Business Communications Co., Inc., 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Frank, Richard G. Pricing, patent loss and the market for pharmaceuticals. National Bureau of Economic Research, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Raggett, Tom. Generic pharmaceuticals: Implications for the global pharmaceutical industry. Financial Times Business Information, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Shah, Hemant K. Changing the rules of the game: The U.S. generic drug industry. Decision Resources, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Philipp, Marc P. Intellectual property related generic defense strategies in the European pharmaceutical market: Implications of the EU Commission's sector inquiry from an IP, competition law and economic perspective. Nomos, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Marc, Favreau. The semiconductor industry: Devices, materials, equipment, fabs. Business Communications Co., Inc., 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

A, Feinstein Richard, ed. Pay to delay: Are patent settlements that delay generic drug market entry anticompetitive? : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, June 3, 2009. U.S. G.P.O., 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

World Federation of Proprietary Medicine Manufacturers. General Assembly. Globalization of the self-medication market: Challenges and opportunities : proceedings : World Federation of Proprietary Medicine Manufacturers (WFPMM) 11th General Assembly, October 27-30, 1993, Acapulco Princess Hotel, Acapulco, México. F. Wüst, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

C, Braude Monique, Chao Helen M, and National Institute on Drug Abuse., eds. Genetic and biological markers in drug abuse and alcoholism. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Lee, Chi-Jen. Development and evaluation of drugs: From laboratory through licensure to market. CRC Press, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Lee, Chi-Jen. Development and evaluation of drugs: From laboratory through licensure to market. 2nd ed. CRC Press, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

1960-, Murji Karim, and South Nigel, eds. Traffickers: Drug markets and law enforcement. Routledge, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Nigel, South, ed. Eurodrugs: Drug use, markets, and trafficking in Europe. UCL Press, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

M, Hampton Garret, and Sikora Karol, eds. Genomics in cancer drug discovery and development. Elsevier/AP, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Semizarov, Dimitri. Genomics in drug discovery and development. Wiley, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

1966-, Petryna Adriana, Lakoff Andrew 1970-, and Kleinman Arthur, eds. Global pharmaceuticals: Ethics, markets, practices. Duke University Press, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Masaya, Segawa, ed. Hereditary progressive dystonia with marked diurnal fluctuation. Parthenon Pub. Group, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Ralph, Rapley, and Harbron Stuart, eds. Molecular analysis and genome discovery. J. Wiley, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

United States. Congress. House. Committee on Banking and Financial Services. Subcommittee on General Oversight and Investigations. Law enforcement efforts to combat international money laundering through black market peso brokering: Hearing before the Subcommittee on General Oversight and Investigations of the Committee on Banking and Financial Services, House of Representatives, One Hundred Fifth Congress, first session, October 22, 1997. U.S. G.P.O., 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Generic drugs: Markets, developments, opportunities. Business Communications Co., 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

U.S. prescription generic pharmaceuticals markets. Frost & Sullivan, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

The Generic drug market in the U.S. Frost & Sullivan, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Crandall, Mary Anne. The market for prescription generic drugs (A Kalorama Information market intelligence report). Kalorama Information, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Elder, Melissa. The Market for RX-To-OTC Switches (Kalorama Information Market Intelligence Report). Find/Svp, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Feldman, Robin, and Evan Frondorf. Drug Wars: How Big Pharma Raises Prices and Keeps Generics off the Market. Cambridge University Press, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Feldman, Robin, and Evan Frondorf. Drug Wars: How Big Pharma Raises Prices and Keeps Generics off the Market. Cambridge University Press, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

author, Frondorf Evan, ed. Drug wars: How big pharma raises prices and keeps generics off the market. Cambridge University Press, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Intelligence, Espicom Business. Biogenerics 2005: An Emerging Global Market? Espicom Business Intelligence, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Manocaran, Merlina. The effect of non-market experience: Evidence from patent challenges in the pharmaceutical industry. 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Hutchison, Melissa. The market for Rx-to-OTC switches (A Kalorama Information market intelligence report). Kalorama Information, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Crandall, Mary Anne. Women's Health: Worldwide Prescription Drug Markets (Kalorama Information Market Intelligence Report). Kalorma Information, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Co, Business Communications. Genomics-Based Approaches to Drug Target Validation. Business Communications Company, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Reports, Energy Business. European Generic Drug Market Potential. Independent Publisher, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Atkinson, Timothy. European Generic Drug Markets. Urch Publishing Ltd, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Schweitzer, Stuart O., and Z. John Lu. Pharmaceutical Economics and Policy. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190623784.001.0001.

Full text

Abstract:

Pharmaceuticals play a critical role in the raging debate over how best to advance and improve healthcare in the United States and the rest of the world. Using the analytical tools of economics, this book explores the conflicting priorities and aims of the biopharmaceutical industry. It starts out by describing the supply side of pharmaceuticals in all its forms, including the traditional pharmaceutical sector, the biotechnology sector, and the generic sector, as well as the increased blending among them. It next turns to the demand side, looking at the determinants of demand for pharmaceutica

APA, Harvard, Vancouver, ISO, and other styles

43

Chatterjee, Chirantan, and Shreekanth Mahendiran. From ‘Pharmacy’ to ‘Laboratory’. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780199476084.003.0005.

Full text

Abstract:

This chapter explores how the Indian pharmaceutical industry, will respond to this shift in market opportunity and technological paradigm in the global biopharmaceutical industry. It examines whether firms in the industry will be able to cater to the global demand for biologics-based drugs and/or its generic version, biosimilars. It uses quantitative analyses of scientific and innovation capabilities of domestic firms from India and also conducts an econometric analysis of India’s market-based demand for biological products, arguing that these would provide early markers for the industry’s fut

APA, Harvard, Vancouver, ISO, and other styles

44

Schweitzer, Stuart O., and Z. John Lu. Patent Protection. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190623784.003.0012.

Full text

Abstract:

Patent protection, innovation, and profitability are all intimately connected in the pharmaceutical industry. Without patent protection there would be no marketing exclusivity, and competitors would immediately enter any market where there was a new successful drug, eventually driving price down to the marginal production cost. Future R&D would never take place because there would be no way for firms to earn a yield on those investments in developing new pharmaceuticals. Patents, however, entail societal cost, because they raise the diffusion cost of knowledge and makes some innovative dru

APA, Harvard, Vancouver, ISO, and other styles

45

(Editor), Tapash K. Ghosh, and William Pfister (Editor), eds. Drug Delivery to the Oral Cavity: Molecules to Market (Drugs and the Pharmaceutical Sciences). Informa Healthcare, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Babor, Thomas, Jonathan Caulkins, Benedikt Fischer, et al. Drug Policy and the Public Good. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780198818014.001.0001.

Full text

Abstract:

Drug Policy and the Public Good presents the accumulated scientific knowledge of direct relevance to the development of drug policy on local, national, and international levels. The book explores both illicit drug use and non-medical use of prescription medications within a public health perspective. A conceptual basis for a rational drug policy is presented, along with new epidemiological data on the global dimensions of drug misuse, significant trends in drug epidemics, and the global burden of disease attributable to drug misuse. The markets for both illicit and legally prescribed psychoact

APA, Harvard, Vancouver, ISO, and other styles

47

Illicit drug markets. United Nations, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Ecks, Stefan. Living Worth. Duke University Press, 2022. http://dx.doi.org/10.1215/9781478022282.

Full text

Abstract:

In Living Worth Stefan Ecks draws on ethnographic research on depression and antidepressant usage in India to develop a new theory of value. Framing depressive disorder as a problem of value, Ecks traces the myriad ways antidepressants come to have value, from their ability to help make one’s life worth living to the wealth they generate in the multibillion-dollar global pharmaceutical market. Through case studies that include analyses of the different valuation of generic and brand-name drugs, the origins of rising worldwide depression rates, and the marketing, prescription, and circulation o

APA, Harvard, Vancouver, ISO, and other styles

49

White, Helene Raskin. Substance Use and Crime. Edited by Kenneth J. Sher. Oxford University Press, 2014. http://dx.doi.org/10.1093/oxfordhb/9780199381708.013.004.

Full text

Abstract:

The author explores the associations between alcohol and drug use and crime. First, general theoretical models of the substance use–crime connection, including substance use causing crime, crime leading to substance use, and a common cause model, are presented. Next, the empirical research that examines situational and global associations between substance use and crime is reviewed, and this research is tied to the explanatory models. The review indicates that the substance-using/crime-committing population is heterogeneous and there are multiple paths that lead to substance use and crime. For

APA, Harvard, Vancouver, ISO, and other styles

50

Yao, Yihong, Bahija Jallal, and Koustubh Ranade. Genomic Biomarkers for Pharmaceutical Development: Advancing Personalized Health Care. Elsevier Science & Technology Books, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!